Kura Oncology, Inc. (KURA)
11.38
-0.18
(-1.60%)
USD |
NASDAQ |
Sep 11, 16:00
11.38
0.00 (0.00%)
After-Hours: 17:07
Kura Oncology Gross Profit (TTM) : 75.37M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.37M |
| March 31, 2026 | 70.17M |
| December 31, 2025 | 66.39M |
| September 30, 2025 | 103.20M |
| June 30, 2025 | 82.40M |
| March 31, 2025 | 67.14M |
| December 31, 2024 | 53.04M |
| September 30, 2024 | -0.858M |
| June 30, 2024 | -0.866M |
| March 31, 2024 | -0.877M |
| December 31, 2023 | -0.849M |
| September 30, 2023 | -0.841M |
| June 30, 2023 | -0.818M |
| March 31, 2023 | -0.788M |
| December 31, 2022 | -0.759M |
| September 30, 2022 | -0.719M |
| June 30, 2022 | -0.686M |
| March 31, 2022 | -0.627M |
| December 31, 2021 | -0.558M |
| September 30, 2021 | -0.50M |
| June 30, 2021 | -0.414M |
| March 31, 2021 | -0.302M |
| December 31, 2020 | -0.194M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.086M |
| June 30, 2020 | -0.012M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.001M |
| March 31, 2019 | -0.005M |
| December 31, 2018 | -0.01M |
| September 30, 2018 | -0.017M |
| June 30, 2018 | -0.023M |
| March 31, 2018 | -0.027M |
| December 31, 2017 | -0.03M |
| September 30, 2017 | -0.031M |
| June 30, 2017 | -0.032M |
| March 31, 2017 | -0.031M |
| December 31, 2016 | -0.031M |
| September 30, 2016 | -0.03M |
| June 30, 2016 | -0.029M |
| March 31, 2016 | -0.025M |
| December 31, 2015 | -0.02M |
| September 30, 2015 | -0.013M |
| June 30, 2015 | -0.006M |
| March 31, 2015 | -0.003M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -3.015M |
| Fortress Biotech, Inc. | 40.31M |
| Syndax Pharmaceuticals, Inc. | 241.59M |
| Spero Therapeutics, Inc. | 0.00 |
| Gossamer Bio, Inc. | 52.36M |